Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.

@article{Baldy2004ImmunogenicityOT,
  title={Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination.},
  author={Jos{\'e} Lu{\'i}s da Silveira Baldy and Gerson Zanetta de Lima and Helena Kaminami Morimoto and Edna Maria Vissoci Reiche and Tiemi Matsuo and Edlivia Dias de Mattos and Luci Cristina Pulga Sudan},
  journal={Revista do Instituto de Medicina Tropical de Sao Paulo},
  year={2004},
  volume={46 2},
  pages={103-7}
}
We evaluated the immunogenicity of three recombinant hepatitis B vaccines, one Brazilian (Butang, Instituto Butantan) and two Korean vaccines (Euvax-B, LG Chemical Ltd. and Hepavax-Gene, Greencross Vaccine Corp.), administered intramuscularly to students aged 17 to 19 years in three 10- micro g doses (corresponding to half the amount of antigen routinely used for adult vaccination) at intervals of one month between the first and second dose, and of four months between the second and third dose… CONTINUE READING